Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology) - Image 1

£108.94

Humana Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)

Name: Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)
Brand: Humana
Price: 108.94 GBP
Availability: InStock

Cardiovascular

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£109 today · all-time low £107 (May 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 56 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (26 days, 46.4%)

Price range: £107 - £121

Price levels: 5 different prices over 56 days

Description

One of the most important developments in the field of cardiovascular medicine over the last two decades has been recognition of the key role played by arterial thrombosis in the pathogenesis of acute coronary syndromes, ischemic complications of percutane ous coronary revascularization, and coronary and peripheral atherosclerosis. The phar macologic armamentarium directed against vascular thrombosis has thus expanded substantially during that time, with development of new fibrinolytic agents, low-molecu lar-weight heparins, direct thrombin inhibitors, antagonists to platelet activation, and the platelet glycoprotein lIb/IlIa inhibitors. Though clinical investigations of these com pounds have been marked by failures as well as successes, there is little doubt that enhanced antithrombotic therapies have markedly improved the outcome of patients undergoing coronary revascularization or with acute coronary syndromes. Glycoprotein IIblIlIa receptor antagonists were introduced into clinical practice to overcome the limitations of approaches that inhibit only individual pathways of platelet activation. Multiple mechanisms of platelet activation in response to different agonists converge on the platelet membrane glycoprotein IIblIlIa complex, the "final common pathway" of platelet aggregation. The clinical hemorrhagic syndrome caused by a rare inherited defect in this receptor (Glanzmann' s thrombasthenia), characterized by muco cutaneous and postsurgical bleeding, but infrequent spontaneous organ (particularly central nervous system) bleeding, suggested that therapeutic inhibition of this receptor might be a potent, yet well-tolerated means of treating thrombotic disorders.

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 1588291855
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Release Date: 07 March 2003
Listed Since: 05 January 2007

Barcode

No barcode data available

Humana Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)

About as cheap as it gets. The only time it was cheaper was 2 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

XIVth International Symposium on Medicinal Chemistry: Proceedings : Maastricht, the Netherlands, 8-12 September 1996 (Pharmacochemistry Library): Volume 28

Platelet Function: Assessment, Diagnosis, and Treatment (Contemporary Cardiology)

Platelets in Cardiovascular Disease

Antiplatelet Agents: 210 (Handbook of Experimental Pharmacology, 210)

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)

Antiplatelet Agents: 210 (Handbook of Experimental Pharmacology, 210)

Manual of Blood Platelets: Morphology, Physiology and Pharmacology

Hemostasis and Thrombosis: Basic Principles and Clinical Practice

Platelets, Haemostasis and Inflammation: 5 (Cardiac and Vascular Biology, 5)

Humana Anticoagulants, Antiplatelets, and Thrombolytics - 663

Plasminogen–Related Growth Factors: v.212 (Novartis Foundation Symposia)

Platelets, Thrombosis and the Vessel Wall: 6 (Advances in Vascular Biology)

Hemostasis and Thrombosis: Methods and Protocols: 1646 (Methods in Molecular Biology, 1646)

Energetics of Secretion Responses: Volume I: 1 (CRC Press Revivals)

Platelets in Hematologic and Cardiovascular Disorders: A Clinical Handbook

Clopidogrel and the Newer P2Y12 Antiplatelet Agents: Pharmacology, Clinical Uses, and Adverse Effects

Handbook of Platelet Physiology and Pharmacology

The Coagulation Consult: A Case-Based Guide

The Coagulation Consult: A Case-Based Guide

Springer - Recent Advances in Thrombosis and Hemostasis Book

Platelet Protocols: Research and Clinical Laboratory Procedures

Blombäck's Essential Guide to Blood Coagulation: A Practical Guide to Diagnosis and Treatment of Hemostatic Disorders

Practical Hemostasis and Thrombosis

Hämostaseologie: Grundlagen, Diagnostik und Therapie